Contralateral Breast Cancer Risk among Carriers of Germline Pathogenic Variants in ATM, BRCA1, BRCA2, CHEK2, and PALB2

  1. Yadav, S.
  2. Boddicker, N.J.
  3. Na, J.
  4. Polley, E.C.
  5. Hu, C.
  6. Hart, S.N.
  7. Gnanaolivu, R.D.
  8. Larson, N.
  9. Holtegaard, S.
  10. Huang, H.
  11. Dunn, C.A.
  12. Teras, L.R.
  13. Patel, A.V.
  14. Lacey, J.V.
  15. Neuhausen, S.L.
  16. Martinez, E.
  17. Haiman, C.
  18. Chen, F.
  19. Ruddy, K.J.
  20. Olson, J.E.
  21. John, E.M.
  22. Kurian, A.W.
  23. Sandler, D.P.
  24. O'Brien, K.M.
  25. Taylor, J.A.
  26. Weinberg, C.R.
  27. Anton-Culver, H.
  28. Ziogas, A.
  29. Zirpoli, G.
  30. Goldgar, D.E.
  31. Palmer, J.R.
  32. Domchek, S.M.
  33. Weitzel, J.N.
  34. Nathanson, K.L.
  35. Kraft, P.
  36. Couch, F.J.
  37. Mostrar todos os autores +
Revista:
Journal of Clinical Oncology

ISSN: 1527-7755 0732-183X

Ano de publicación: 2023

Volume: 41

Número: 9

Páxinas: 1703-1713

Tipo: Artigo

DOI: 10.1200/JCO.22.01239 GOOGLE SCHOLAR lock_openAcceso aberto editor